Solventum Corporation (SOLV) Financial Analysis & Valuation | Quarter Chart
Solventum Corporation (SOLV)
SOLVPrice: $78.24
Fair Value: 🔒
🔒score
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtratio... more
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercia... more
Description
Shares
| Market Cap | $13.55B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Care Facilities |
| Country | US | CEO | Bryan C. Hanson |
| IPO Date | 2024-04-01 | CAGR | 0.03% |
| Employees | 22,000 | Website | www.solventum.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.48% | Total Yield | 0.48% |
SOLV chart loading...
Fundamentals
Technicals
| Enterprise Value | $16.14B | P/E Ratio | 12.54 |
| Forward P/E | 11.1 | PEG Ratio | -0.11 |
| P/S Ratio | 1.67 | P/B Ratio | 2.79 |
| P/CF Ratio | 91.92 | P/FCF Ratio | -67.96 |
| EPS | $6.24 | EPS Growth 1Y | 276.5% |
| EPS Growth 3Y | 9.72% | EPS Growth 5Y | — |
| Revenue Growth 1Y | -0.55% | Gross Margin | 0.54% |
| Operating Margin | 0.26% | Profit Margin | 0.17% |
| ROE | 0.31% | ROA | 0.1% |
| ROCE | 0.2% | Current Ratio | 1.07 |
| Quick Ratio | 0.75 | Cash Ratio | 0.17 |
| Debt/Equity | 1.02 | Interest Coverage | 6.92 |
| Altman Z Score | 2.14 | Piotroski Score | 6 |